Cary Street Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,392
Closed -$236K 864
2024
Q4
$236K Buy
+16,392
New +$254K 0.01% 677

Other funds holding BMEZ

Cary Street Partners's BMEZ Position: Q1 2025 in Review

Cary Street Partners sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2025, closing a stake of 16,392 shares — an estimated $236K sold.

Cary Street Partners first reported a position in BMEZ in Q4 2024 and held it in 1 quarter. The position peaked at $236K in Q4 2024. 98 funds tracked by Wall St. Rank hold BMEZ as of Q1 2025.

  • Cary Street Partners reported no remaining BlackRock Health Sciences Trust II position as of Q1 2025 after selling out during the quarter.
  • Cary Street Partners sold 16,392 BlackRock Health Sciences Trust II shares in Q1 2025, an estimated $236K.
  • Cary Street Partners first reported a position in BlackRock Health Sciences Trust II in Q4 2024 and held it in 1 quarter.
  • Cary Street Partners's BlackRock Health Sciences Trust II position peaked at $236K in Q4 2024.
  • 98 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2025.

Based on Cary Street Partners's 13F filing for Q1 2025, filed 9 May 2025.